Cited by 326Adipokines, Inflammation, and Metabolic DiseasesAngiogenesis and VEGF in CancerAdipose Tissue and Metabolism

Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice

Open access
Bråkenhielm, Ebba, Cao, Renhai, Gao, Bihu, Angelin, Bo, Cannon, Barbara, Parini, Paolo, Cao, Yihai·2004·Circulation Research

Abstract

Adipose tissue growth has been proposed to involve recruitment of new blood vessels. Here, we test the hypothesis that delivery of an angiogenesis inhibitor in mice may prevent diet-induced obesity, the most common type of obesity in humans. We show that systemic administration of a selective angiogenesis inhibitor, TNP-470 (AGM-1470), prevents obesity in high caloric diet-fed wt mice as well as in genetically leptin-deficient ob/ob mice. Inhibition of obesity in mice by TNP-470 involves a reduction of vascularity in the adipose tissue. This therapeutic strategy appears to selectively affect the growth of adipose tissue as measured by the ratio between total fat and lean body mass. Interestingly, the treatment with TNP-470 results in decreased serum levels of low-density lipoprotein cholesterol. Furthermore, insulin levels are reduced, which indicates increased insulin sensitivity, suggesting that angiogenesis inhibitors may prevent the development of type II diabetes. Our findings suggest that similarly to growth and organogenesis in other tissues, adipose tissue growth is dependent on angiogenesis. Our observations may have conceptual implications for the prevention of obesity and related disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.res.0000132745.76882.70

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Chemical angiogenic inhibitors such as angiostatin, endostatin, thalidomide, and VEGFR2-blocking antibody TNP-470 reduce body weight and fat pad mass in diet-induced obese or genetically obese ob/ob mice.

    “Chemical angiogenic inhibitors such as angiostatin, endostatin, and thalidomide as well as the VEGFR2-blocking antibody TNP-470, have been tested in diet-induced obese mice or genetically obese ob/ob mice and shown to significantly reduce body weight and fat pad mass (88,89).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bråkenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., Parini, P., & Cao, Y.
Affiliations
  • From the Microbiology and Tumor Biology Center (E.B., R.C., Y.C.), Karolinska Institutet, Stockholm, Sweden; The Wenner-Gren Institute (B.G., B.C.), The Arrhenius Laboratories F3, Stockholm University, Stockholm, Sweden; and Metabolism Unit (B.A., P.P.), Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition, Center for Nutrition and Toxicology, Novum, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden.
  • Stockholm University (SE)
Venue
Circulation Research
Published
2004-06-25
Volume
94
Issue
12
Pages
1579-1588
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2098387318
Cited by
326
References
38
Citations by year
2026: 5 · 2025: 2 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 7 · 2020: 10 · 2019: 16 · 2018: 18 · 2017: 22 · 2016: 12 · 2015: 11 · 2014: 22 · 2013: 35 · 2012: 20
FWCI
9.82
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancerfonden
  • Vetenskapsrådet
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
TNP-470, angiogenesis inhibitors, diet-induced obesity, genetic obesity, ob/ob mice, leptin deficiency, adipose tissue expansion, LDL cholesterol, insulin sensitivity, type 2 diabetes prevention
MeSH terms
O-(Chloroacetylcarbamoyl)fumagillol, Adipose Tissue, Animals, Body Composition, Cattle, Cornea, Cyclohexanes, Dietary Fats, Drug Evaluation, Preclinical, Endothelium, Vascular, Insulin Resistance, Lipids, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, Oxygen Consumption, Sesquiterpenes, Neovascularization, Physiologic, Anti-Obesity Agents, Angiogenesis Inhibitors, 3T3-L1 Cells, Endothelial Cells, Carbohydrate Metabolism, Lipid Metabolism, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review